REFERENCES
- Moyer, J. H., Kent, B., Knight, R., Morris, G., Huggins, R. and Handley, C. A.: Laboratory and clinical observations on chlorpromazine (SKF-2601-A); hemodynamic and toxicological studies. Am. J. M. Sc. 227: 283–290 (March) 1954.
- Vischer, T. J.: Clinical study of proclorperazine, a new tranquilizer for the treatment of nonhospitalized psychoneurotic patients. New England J. Med. 256: 26–27 (January 3) 1957.
- Smithy, G. and Homburger, F.: Proclorperazine for the treatment of nausea and vomiting in patients with advanced cancer and other chronic diseases. New England J. Med. 256: 27–28 (January 3) 1957.
- Mitchell, E. H.: Treatment of acute alcoholism with promazine (Sparine). J.A.M.A. 161: 44–45 (May 5) 1956.
- Fazekas, J. F., Schultz, J. D., Sullivan, P. D. and Shea, J. G.: Management of acutely disturbed patients with promazine (Sparine). J.A.M.A. 161: 46–49 (May 5) 1956.
- Kline, N. S. and Jacob, G. M.: Use of Pacatal (N-methylpiperidyl-[3]-methylphenothiazine in psychiatric patients. Am. J. Psychiat. 112: 63 (July) 1955.
- Burke, J. C., Hassert, G. L., Jr. and High, J. P.: The tranquilizing activity of 10-(3-dimethylaminopropyl)-2-(trifluoromethyl)-phenothiazine hydrochloride (MC 4703) and related phenothiazines in animals. J. Pharmacol. & Exper. Therap. 119: 136 (February) 1957.
- Piala, J. J., High, J. P., Greenspan, K. and Burke, J. C.: Further laboratory observations on 10-(3-dimethylaminopropyl)-2-(trifluoromethyl)-phenothiazine hydrochloride (MC 4703). J. Pharmacol. & Exper. Therap. 119: 176–177 (February) 1957.
- Wilkins, R. W., Judson, W. E., Stone, R. W., Hollander, W., Huckabee, W. E. and Friedman, I. H.: Reserpine in the treatment of hypertension: A note on the relative dosage and effects. New England J. Med. 250: 477–478 (March 18) 1954.
- Kline, N. S.: Use of Rauwolfia serpentina benth. in neuropsychiatric conditions. Ann. New York Acad. Sc. 59: 107–132 (April 30) 1954.
- Moyer, J. H., Dennis, E. and Ford, R.: Drug therapy (Rauwolfia) of hypertension. II. A comparative study of different extracts of Rauwolfia when each is used alone (orally) for therapy of ambulatory patients with hypertension. A.M.A. Arch. Int. Med. 96: 530–543 (October) 1955.
- Brunings, K. J.: Drug lowers blood pressure and anxiety. Science Newsletter 70: 376 (December 15) 1956.
- Keeping drunks sober. Science Newsletter 68: 159 (September 3) 1955.
- Turvey, S. E. C.: Meprobamate (Equanil) for relief of anxiety and nervous tension from various causes. Canad. M.A.J. 74: 863–865 (June 1) 1956.
- Selling, L. S.: Clinical study of a new tranquilizing drug: Use of Miltown (2-methyl-2-N-propyl-1,3-propanediol dicarbamate). J.A.M.A. 157: 1594–1596 (April 30) 1955.
- Borrus, J. C.: Study of effect of Miltown (2-methyl-2-N-propyl-1,3-propanediol dicarbamate) on psychiatric states. J.A.M.A. 157: 1596–1598 (April 30) 1955.
- Robinson, H. M., Jr., Robinson, R. C. V. and Strahan, J. F.: Hydroxyzine (Atarax) hydrochloride in dermatological therapy. J.A.M.A. 161: 604–606 (June 16) 1956.
- Shalowitz, M.: Hydroxyzine: A new therapeutic agent for senile anxiety states; a preliminary report. Geriatrics 11: 312–316 (July) 1956.
- Alexander, L.: Therapeutic progress in electroshock and the newer drug therapies; psychopathological considerations. J.A.M.A. 162: 966–969 (November 3) 1956.
- Himwich, H. E. and Rinaldi, F.: The antiparkinson activity of benactyzine. Arch. internat. pharmacodyn. 110: 119–127 (March 1) 1957.
- Fabing, H. D.: Frenquel, a blocking agent against experimental LSD-25 and mescaline psychosis: Preliminary note on its clinical application. Neurology 5: 319–328 (May) 1955.
- Jellinek, E. M.: Clinical tests on comparative effectiveness of analgesic drugs. Biometric Bull. 2: 87, 1946.
- Lasagna, L., Mosteller, F., Von Felsinger, J. M. and Beecher, H. K.: A study of the placebo response. Am. J. Med. 16: 770–779 (June) 1954.